Physician
Austin Regional Clinic, PA
Austin Regional Clinic, PA was paid $14.70M by Medicaid between Jan 2018 and Dec 2024, across 104 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoAUSTIN REGIONAL CLINIC, PA
AUSTIN, TX 78723
AUSTIN, TX 78723
33aNPI1821157579assigned 12/08/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$14.70M
24GClaims495,485
24DCodes billed104
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Texas
Rank by total paid#2 of 62
Median peer was paid$91K
This provider vs. median162×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,140 | $61K | |
| 2019 | 2,375 | $54K | |
| 2020 | 13,996 | $356K | |
| 2021 | 116,929 | $3.63M | |
| 2022 | 132,437 | $4.14M | |
| 2023 | 127,988 | $3.61M | |
| 2024incomplete | 99,620 | $2.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 141,465 | 134,394 | $5.17M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.3% | 120,521 | 48,510 | $1.37M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.0% | 15,051 | 14,492 | $1.17M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.8% | 13,997 | 13,952 | $1.15M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.7% | 14,403 | 13,112 | $1.13M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 18,714 | 17,743 | $937K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.3% | 7,874 | 6,436 | $920K |
| 99050 | 5.4% | 28,995 | 28,542 | $790K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 5,513 | 5,495 | $479K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.0% | 11,609 | 10,542 | $293K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 11,430 | 8,606 | $250K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 2,346 | 2,338 | $217K |
92 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 6,392 | $191K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 10,900 | $93K |
| 90461 | <1% | 27,833 | $84K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 506 | $66K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 772 | $59K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 687 | $57K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 407 | $32K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,134 | $24K |
| 99381 | <1% | 220 | $18K | |
| 0071A | <1% | 446 | $18K | |
| 0002A | <1% | 551 | $18K | |
| 0001A | <1% | 527 | $17K | |
| 0072A | <1% | 399 | $17K | |
| 92551 | <1% | 2,472 | $12K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 54 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 349 | $10K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 346 | $10K |
| 99429 | <1% | 559 | $10K | |
| 87800 | <1% | 262 | $10K | |
| 95117 | <1% | 1,006 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 133 | $6K |
| 81513 | <1% | 66 | $6K | |
| 96160 | <1% | 2,106 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 232 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 69 | $4K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 12 | $3K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 340 | $3K |
| 86780 | <1% | 241 | $3K | |
| 99383 | <1% | 26 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 403 | $2K |
| 87481 | <1% | 132 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 188 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 66 | $2K |
| 90686 | <1% | 10,620 | $2K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 13 | $1K |
| 0054A | <1% | 31 | $1K | |
| 96380 | <1% | 74 | $1K | |
| 0003A | <1% | 31 | $1K | |
| 92567 | <1% | 93 | $1K | |
| 0111A | <1% | 25 | $1K | |
| 90480 | <1% | 39 | $1K | |
| 99243 | <1% | 12 | $1K | |
| 87340 | <1% | 99 | $822.70 | |
| 86803 | <1% | 74 | $819.86 | |
| 80053 | Comprehensive metabolic panel | <1% | 86 | $691.95 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $689.85 |
| 54150 | <1% | 12 | $667.20 | |
| 86762 | <1% | 51 | $622.43 | |
| 0082A | <1% | 13 | $622.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 68 | $441.44 |
| 87653 | <1% | 14 | $356.39 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 30 | $316.60 |
| 90677 | <1% | 2,845 | $258.35 | |
| 85027 | <1% | 36 | $200.31 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24 | $200.24 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $192.87 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $173.56 |
| 80061 | Lipid panel | <1% | 12 | $140.60 |
| 90688 | <1% | 935 | $112.58 | |
| A7006 | Administration set, with small volume filtered pneumatic nebulizer | <1% | 15 | $78.00 |
| 87081 | <1% | 12 | $64.35 | |
| 85018 | <1% | 44 | $60.31 | |
| 90658 | <1% | 238 | $33.05 | |
| 81003 | <1% | 13 | $25.84 | |
| 0011A | <1% | 22 | $16.94 | |
| 90619 | <1% | 94 | $0.12 | |
| 90670 | <1% | 6,553 | $0.01 | |
| 90698 | <1% | 9,305 | $0.01 | |
| 90680 | <1% | 3,269 | $0.01 | |
| 90651 | <1% | 359 | $0.01 | |
| 90620 | <1% | 12 | $0.01 | |
| 3078F | 0% | 443 | $0.00 | |
| 99173 | 0% | 1,099 | $0.00 | |
| 90633 | 0% | 1,222 | $0.00 | |
| 90734 | 0% | 101 | $0.00 | |
| 90707 | 0% | 61 | $0.00 | |
| 90672 | 0% | 28 | $0.00 | |
| 90681 | 0% | 99 | $0.00 | |
| 90710 | 0% | 28 | $0.00 | |
| 90715 | 0% | 13 | $0.00 | |
| 90380 | 0% | 14 | $0.00 | |
| 90744 | 0% | 1,703 | $0.00 | |
| 3074F | 0% | 1,523 | $0.00 | |
| 96127 | 0% | 88 | $0.00 | |
| 90656 | 0% | 692 | $0.00 | |
| 0012A | 0% | 18 | $0.00 | |
| 90723 | 0% | 107 | $0.00 | |
| 96161 | 0% | 37 | $0.00 | |
| 90647 | 0% | 146 | $0.00 | |
| 90716 | 0% | 49 | $0.00 | |
| 90696 | 0% | 26 | $0.00 | |
| 90381 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAGHESTANI, ANAS (CEO/PRESIDENT)